203 related articles for article (PubMed ID: 24597649)
1. Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response.
Lasfar A; Cook JR; Cohen Solal KA; Reuhl K; Kotenko SV; Langer JA; Laskin DL
Immunology; 2014 Jul; 142(3):442-52. PubMed ID: 24597649
[TBL] [Abstract][Full Text] [Related]
2. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
3. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.
Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S
Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564
[TBL] [Abstract][Full Text] [Related]
4. Neuronal Ablation of Alpha/Beta Interferon (IFN-α/β) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-γ Responsiveness in Microglia/Macrophages.
Hwang M; Bergmann CC
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796063
[TBL] [Abstract][Full Text] [Related]
5. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
6. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
7. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the involvement of type I interferon in pulmonary arterial hypertension.
George PM; Oliver E; Dorfmuller P; Dubois OD; Reed DM; Kirkby NS; Mohamed NA; Perros F; Antigny F; Fadel E; Schreiber BE; Holmes AM; Southwood M; Hagan G; Wort SJ; Bartlett N; Morrell NW; Coghlan JG; Humbert M; Zhao L; Mitchell JA
Circ Res; 2014 Feb; 114(4):677-88. PubMed ID: 24334027
[TBL] [Abstract][Full Text] [Related]
9. The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis.
Naves R; Singh SP; Cashman KS; Rowse AL; Axtell RC; Steinman L; Mountz JD; Steele C; De Sarno P; Raman C
J Immunol; 2013 Sep; 191(6):2967-77. PubMed ID: 23960239
[TBL] [Abstract][Full Text] [Related]
10. The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence.
Subramaniam PS; Johnson HM
FEBS Lett; 2004 Dec; 578(3):207-10. PubMed ID: 15589821
[TBL] [Abstract][Full Text] [Related]
11. Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R.
Harris BD; Schreiter J; Chevrier M; Jordan JL; Walter MR
J Biol Chem; 2018 Oct; 293(41):16057-16068. PubMed ID: 30171073
[TBL] [Abstract][Full Text] [Related]
12. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.
Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A
Front Immunol; 2018; 9():2589. PubMed ID: 30473701
[TBL] [Abstract][Full Text] [Related]
13. Multifaceted activities of type I interferon are revealed by a receptor antagonist.
Levin D; Schneider WM; Hoffmann HH; Yarden G; Busetto AG; Manor O; Sharma N; Rice CM; Schreiber G
Sci Signal; 2014 May; 7(327):ra50. PubMed ID: 24866020
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis.
Roh YS; Park S; Kim JW; Lim CW; Seki E; Kim B
Hepatology; 2014 Jul; 60(1):237-49. PubMed ID: 24375615
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic Type 1 Interferon Responses Are Critical for Control of Systemic Reovirus Dissemination.
Phillips MB; Dina Zita M; Howells MA; Weinkopff T; Boehme KW
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208448
[TBL] [Abstract][Full Text] [Related]
16. Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation.
Müller E; Speth M; Christopoulos PF; Lunde A; Avdagic A; Øynebråten I; Corthay A
Front Immunol; 2018; 9():2520. PubMed ID: 30450098
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive comparison of thirteen kinds of cytokine receptors from the endangered fish Chinese sturgeon (Acipenser sinensis).
Xu Q; Deng D; Guo H; Yuan H; Zhang W; Wang B; Lu Y; Chen D; Zhang S
Dev Comp Immunol; 2021 Oct; 123():104132. PubMed ID: 34038788
[TBL] [Abstract][Full Text] [Related]
18. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice.
Petrasek J; Dolganiuc A; Csak T; Kurt-Jones EA; Szabo G
Gastroenterology; 2011 Feb; 140(2):697-708.e4. PubMed ID: 20727895
[TBL] [Abstract][Full Text] [Related]
19. Functional crosstalk between type I and II interferon through the regulated expression of STAT1.
Gough DJ; Messina NL; Hii L; Gould JA; Sabapathy K; Robertson AP; Trapani JA; Levy DE; Hertzog PJ; Clarke CJ; Johnstone RW
PLoS Biol; 2010 Apr; 8(4):e1000361. PubMed ID: 20436908
[TBL] [Abstract][Full Text] [Related]
20. Characterization of interferon α and β receptor IFNAR1 and IFNAR2 expression and regulation in the uterine endometrium during the estrous cycle and pregnancy in pigs.
Jang H; Choi Y; Yoo I; Han J; Kim M; Ka H
Theriogenology; 2017 Jan; 88():166-173. PubMed ID: 27769575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
